Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
10/10/2022
Updated
10/11/22, 11:00 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership